Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery after Induction Chemoradiotherapy in Stage IIIB NSCLC
NCT00021112Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 2001
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of cisplatin, etoposide in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 2001; status: terminated.
02
Drugs
cisplatinetoposide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00021112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021112.